citation,pmid
"Reiser J, Gupta V, Kistler AD. Toward the development of podocyte-specific drugs. Kidney Int. 2010 Apr;77(8):662–8.",20130528
"Canaud G, Martinez F, Noël L-H, Mamzer M-F, Niaudet P, Legendre C. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev (Orlando). 2010 Jul;24(3):121–8.",20537521
Howie AJ. Problems with “focal segmental glomerulosclerosis.” Pediatr Nephrol. 2011 Aug;26(8):1197–205.,21125407
Meyrier A. Focal and segmental glomerulosclerosis: multiple pathways are involved. Semin Nephrol. 2011 Jul;31(4):326–32.,21839365
"Rood IM, Deegens JKJ, Wetzels JFM. Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol Dial Transplant. 2012 Mar;27(3):882–90.",22334613
"Kato H, Susztak K. Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis. Semin Nephrol. 2012 Jul;32(4):350–6.",22958489
"Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med. 2013 Apr;19(4):481–7.",23502960
